As of 26 Oct 2026 09:04 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2025/050 (26 Aug 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Repaglinide 500microgram and 1mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | early December 2025precision: early in the month · window end 10 Dec 2025, derived from “early December 2025” | notice of 26 Aug 2025 |
| Repaglinide 2mg tabletsaffected product · inferred from phrasing | Limited supply, as stated⚠ the source line states more than one status — first stated shown | early December 2025precision: early in the month · window end 10 Dec 2025, derived from “early December 2025” | notice of 26 Aug 2025 |
| Alternative glucose lowering medicationclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 26 Aug 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Repaglinide
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 26 Aug 2025. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 26 Aug 2025 | Medicine Supply Notification: Repaglinide 500microgram,1mg and 2mg tablets | Supply notification | Tier 2 | MSN/2025/050 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)42 Repaglinide 500microgram,1mg and 2mg tablets · issued 28 Aug 2025 · valid until early December 2025, as stated · matched by name PDF ↗
- MSAN(2021)11 Repaglinide 1mg and 2mg tablets · issued 16 Mar 2021 · valid until early May 2021, as stated · matched by name PDF ↗